Refine Results
- Products
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 20 of 20 results
LC/MS based characterization workflow of the GLP-1 therapeutic peptide liraglutide and its impurities using the 1290 Infinity II LC and 6545XT AdvanceBio LC/Q-TOF.
In this application note, a method for the quantification of mutagenic Nitrosamine drug substance related impurity is described.
A method describing the detection of 12 potentially mutagenic nitrosamine impurities found in sartan drugs using the Ultivo LC/TQ
| Korean (Korea) | Complete (PDF) |
|---|---|
| Japanese (Japan) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
| Italian (Italy) | Complete (PDF) |
Sensitive, high-resolution LC/MS/MS method using the Agilent 6546 LC/Q-TOF for the detection and quantification of the nitrosamine impurities
| Japanese (Japan) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
A LC/MS/MS based method for the quantitation of ‘N-nitroso Bumetanide impurity’ in Bumetanide API and low dose tablets.
A highly sensitive LC/MS/MS method for the simultaneous determination of eight nitrosamine impurities in metformin drug substance and drug products.
In this application note, we have developed a highly sensitive triple quadrupole-based LC/MS/MS method for the simultaneous determination of eight nitrosamine impurities in metformin drug substance.
This application note describes an LC/MS/MS method using the Agilent 6470A triple quadrupole LC/MS for the detection and quantification of NDMA in ranitidine drug substances and products.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| Korean (Korea) | Complete (PDF) |
This application note describes a sensitive, high-resolution LC/MS/MS method using the 6546 LC/Q-TOF for the detection and quantification of NDMA in ranitidine drug substance and products.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| Korean (Korea) | Complete (PDF) |
| Japanese (Japan) | Complete (PDF) |
Demonstrates simple and fast sample submission with the Agilent InfinityLab LC/MSD iQ for multiple users utilizing the sample purity workflow in an open-access environment.
| Russian (Russia) | Complete (PDF) |
|---|---|
| Japanese (Japan) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
Analysis of Brand versus Generic Medication Using the LC/MSD iQ for Mass Confirmation
| Russian (Russia) | Complete (PDF) |
|---|
Using the Agilent LC/MSD XT and Agilent InfinityLab Poroshell 120 HILIC-Z column for sensitive and reliable detection of delfampridine impurities
Analysis of pharmaceutical tablets by LC mass selective detection.
Agilent 6530 Q-TOF LC/MS system
Determine potency, and quantitatively profile the 11 most commonly targeted cannabinoids.
Benefits of mass detection for unambiguous peak identification and compound library searching with the InfinityLab LC/MSD system.
Extractables analysis using high resolution LC/MS system and sample comparison using Agilent Mass Profiler Software.
本文介紹了采用配置 APCI 源的 Agilent 6470 三重四極桿液質(zhì)聯(lián)用系統(tǒng)，同時(shí)檢測(cè)沙坦藥物中六種亞硝胺類基因毒性雜質(zhì) NDMA、NDEA、NMBA、NEIPA、NDIPA 和 NDBA 的方法。
本文介紹了采用 Agilent Ultivo 三重四極桿液質(zhì)聯(lián)用系統(tǒng)檢測(cè)氯沙坦鉀中的亞硝胺類雜質(zhì) NMBA 的方法。該方法采用常規(guī) ESI 源，即可獲得滿足檢測(cè)要求的分析結(jié)果，且方法簡(jiǎn)單、特異性高、靈敏度高，大大優(yōu)于 FDA 官網(wǎng)公布的限量要求。